Format

Send to

Choose Destination
Ann Vasc Surg. 2016 Aug;35:98-103. doi: 10.1016/j.avsg.2016.01.046. Epub 2016 May 27.

Barrier Patch Implantation during Redo Surgery for Varicose Vein Recurrences in the Groin: 1-Year Results.

Author information

1
Department of Vascular Surgery and Phlebology, Bethanien Hospital, Moers, Germany.
2
Department of Vascular Surgery and Phlebology, Bethanien Hospital, Moers, Germany. Electronic address: bruno.geier@rub.de.
3
Department of Vascular Surgery and Interdisciplinary Vein Center, St. Josef-Hospital, Ruhr-University, Bochum, Germany.
4
Department of Dermatology and Interdisciplinary Vein Center, St. Josef-Hospital, Ruhr-University, Bochum, Germany.

Abstract

BACKGROUND:

Rerecurrences after redo surgery for recurrent varicose veins in the groin are a common problem. The present report looks at the efficacy of an additional barrier patch implantation in reducing these rerecurrences.

METHODS:

A retrospective review of a prospectively collected database was conducted. This included 67 patients with 86 legs who underwent redo-groin surgery for symptomatic recurrences. In addition, a polytetrafluoroethylene-barrier patch was placed at the former saphenofemoral junction. All patients had undergone ligation and stripping of the great saphenous vein a mean of 13.9 years earlier. All patients were examined by duplex ultrasound before and 1 year after the procedure.

RESULTS:

Perioperatively, minor complications occurred in 5.8% of cases, the groin infection rate was 2.4%. In 85 of 86 legs, the duplex follow-up examination was performed after 1 year. This revealed an overall rerecurrence rate of 12%, of which only 2.4% were caused by recurrent neovascularization in the groin bypassing the barrier patch. The remaining 9.6% were caused by different sites of reflux (pelvic veins and perforators).

CONCLUSIONS:

Redo-groin surgery with additional barrier patch implantation seems to be a safe and effective way to prevent rerecurrences in the groin. In our experience, it provided very promising 1-year results with a very low rate of recurrent neovascularization.

PMID:
27241869
DOI:
10.1016/j.avsg.2016.01.046
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center